Abstract
Sleep has a homeostatic role in the regulation of the immune system and serves to constrain activation of inflammatory signalling and expression of cellular inflammation. In patients with rheumatoid arthritis (RA), a misaligned inflammatory profile induces a dysregulation of sleep–wake activity, which leads to excessive inflammation and the induction of increased sensitivity to pain. Given that multiple biological mechanisms contribute to sleep disturbances (such as insomnia), and that the central nervous system communicates with the innate immune system via neuroendocrine and neural effector pathways, potential exists to develop prevention opportunities to mitigate the risk of insomnia in RA. Furthermore, understanding these risk mechanisms might inform additional insomnia treatment strategies directed towards steering and reducing the magnitude of the inflammatory response, which together could influence outcomes of pain and disease activity in RA.
Key points
-
Patients with rheumatoid arthritis (RA), a chronic inflammatory disorder, frequently complain of symptoms of insomnia and pain.
-
Inflammation can induce sleep disturbance, and in turn sleep disturbance increases inflammation in a feedforward loop, which is sustained by sympathetic arousal mechanisms and a downregulation of glucocorticoid receptor sensitivity.
-
Sleep disturbance can also increase pain sensitivity, as mediated by increases in inflammation; in patients with RA, sleep loss induces heightened pain responses and activation of arthritis-related joint pain.
-
Interventions that treat insomnia have the potential to interrupt the effects of sleep disturbance on inflammation, pain sensitivity and symptomatic progression in patients with RA.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gravallese, E. M. & Firestein, G. S. Rheumatoid arthritis — common origins, divergent mechanisms. N. Engl. J. Med. 388, 529–542 (2023).
Alivernini, S., Firestein, G. S. & McInnes, I. B. The pathogenesis of rheumatoid arthritis. Immunity 55, 2255–2270 (2022).
Krueger, J. M., Frank, M. G., Wisor, J. P. & Roy, S. Sleep function: toward elucidating an enigma. Sleep. Med. Rev. 28, 46–54 (2016).
Brown, R. E., Basheer, R., McKenna, J. T., Strecker, R. E. & McCarley, R. W. Control of sleep and wakefulness. Physiol. Rev. 92, 1087–1187 (2012).
Buysse, D. J., Ancoli-Israel, S., Edinger, J. D., Lichstein, K. L. & Morin, C. M. Recommendations for a standard research assessment of insomnia. Sleep 29, 1155–1173 (2006).
Rechtschaffen, A. & Kales, A. (eds) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects (US National Institute of Neurological Diseases and Blindness, 1968).
Ehlers, C. L., Havstad, J. W., Garfinkel, A. & Kupfer, D. J. Nonlinear analysis of EEG sleep states. Neuropsychopharmacology 5, 167–176 (1991).
Ancoli-Israel, S. et al. The role of actigraphy in the study of sleep and circadian rhythms. Sleep 26, 342–392 (2003).
American Psychiatric Association & American Psychiatric Association. DSM-5 Task Force. Diagnostic and statistical manual of mental disorders : DSM-5. 5th edn (American Psychiatric Association, 2013).
Morin, C. M., Belleville, G., Belanger, L. & Ivers, H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 34, 601–608 (2011).
Irwin, M. R. Sleep and inflammation: partners in sickness and in health. Nat. Rev. Immunol. 19, 702–715 (2019).
Besedovsky, L., Lange, T. & Haack, M. The sleep-immune crosstalk in health and disease. Physiol. Rev. 99, 1325–1380 (2019).
McAlpine, C. S. et al. Sleep exerts lasting effects on hematopoietic stem cell function and diversity. J. Exp. Med. https://doi.org/10.1084/jem.20220081 (2022).
McAlpine, C. S. et al. Sleep modulates haematopoiesis and protects against atherosclerosis. Nature 566, 383–387 (2019).
Carroll, J. E. et al. Epigenetic aging and immune senescence in women with insomnia symptoms: findings from the Women’s Health Initiative Study. Biol. Psychiatry 81, 136–144 (2017).
Westermann, J., Lange, T., Textor, J. & Born, J. System consolidation during sleep — a common principle underlying psychological and immunological memory formation. Trends Neurosci. 38, 585–597 (2015).
Pace-Schott, E. F. & Spencer, R. M. Sleep-dependent memory consolidation in healthy aging and mild cognitive impairment. Curr. Top. Behav. Neurosci. 25, 307–330 (2015).
Spira, A. P., Chen-Edinboro, L. P., Wu, M. N. & Yaffe, K. Impact of sleep on the risk of cognitive decline and dementia. Curr. Opin. Psychiatry 27, 478–483 (2014).
Palmer, C. A. & Alfano, C. A. Sleep and emotion regulation: an organizing, integrative review. Sleep. Med. Rev. 31, 6–16 (2017).
Irwin, M. R. Why sleep is important for health: a psychoneuroimmunology perspective. Annu. Rev. Psychol. 66, 143–172 (2015).
Irwin, M. R. & Vitiello, M. V. Implications of sleep disturbance and inflammation for Alzheimer’s disease dementia. Lancet Neurol. 18, 296–306 (2019).
Morin, C. M., LeBlanc, M., Daley, M., Gregoire, J. P. & Merette, C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep. Med. 7, 123–130 (2006).
Ohayon, M. M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep. Med. Rev. 6, 97–111 (2002).
Morin, C. M. et al. The natural history of insomnia: a population-based 3-year longitudinal study. Arch. Intern. Med. 169, 447–453 (2009).
Van Dyke, M. E., Vaccarino, V., Quyyumi, A. A. & Lewis, T. T. Socioeconomic status discrimination is associated with poor sleep in African-Americans, but not Whites. Soc. Sci. Med. 153, 141–147 (2016).
Drewes, A. M. Pain and sleep disturbances with special reference to fibromyalgia and rheumatoid arthritis. Rheumatology 38, 1035–1038 (1999).
Mustafa, M. et al. Frequency of sleep disorders in patients with rheumatoid arthritis. Open Access Rheumatol. 11, 163–171 (2019).
Freitas, D. C., Schlosser, T. C., dos Santos, A. A., Neri, A. L. & Ceolim, M. F. [Association between insomnia and rheumatoid arthritis in elderly]. Rev. Esc. Enferm. Usp. 47, 869–875 (2013).
Reading, S. R. et al. Do rheumatoid arthritis patients have a higher risk for sleep apnea. J. Rheumatol. 36, 1869–1872 (2009).
Shen, T. C. et al. Risk of obstructive sleep apnoea in patients with rheumatoid arthritis: a nationwide population-based retrospective cohort study. BMJ Open 6, e013151 (2016).
Westhovens, R., Van der Elst, K., Matthys, A., Tran, M. & Gilloteau, I. Sleep problems in patients with rheumatoid arthritis. J. Rheumatol. 41, 31–40 (2014).
Wali, S. et al. Prevalence of obstructive sleep apnea in patients with rheumatoid arthritis. J. Clin. Sleep. Med. 16, 259–265 (2020).
Hirsch, M. et al. Objective and subjective sleep disturbances in patients with rheumatoid arthritis. A reappraisal. Arthritis Rheum. 37, 41–49 (1994).
Drewes, A. M. et al. Sleep in rheumatoid arthritis: a comparison with healthy subjects and studies of sleep/wake interactions. Br. J. Rheumatol. 37, 71–81 (1998).
Mahowald, M. W., Mahowald, M. L., Bundlie, S. R. & Ytterberg, S. R. Sleep fragmentation in rheumatoid arthritis. Arthritis Rheum. 32, 974–983 (1989).
Clarke, L. L., Wilson, S. & Kirwan, J. R. Using actigraphy to measure sleep patterns in rheumatoid arthritis: a pilot study in patients taking night-time prednisone. Musculoskelet. Care 11, 179–185 (2013).
Miyauchi, K., Fujimoto, K., Abe, T., Takei, M. & Ogawa, K. Cross-sectional assessment of sleep and fatigue in middle-aged Japanese women with primary Sjogren syndrome or rheumatoid arthritis using self-reports and wrist actigraphy. Medicine 100, e27233 (2021).
Zamarron, F., Maceiras, F., Mera, A. & Gomez-Reino, J. J. Effects of the first infliximab infusion on sleep and alertness in patients with active rheumatoid arthritis. Ann. Rheum. Dis. 63, 88–90 (2004).
Moldofsky, H., Lue, F. A. & Smythe, H. A. Alpha EEG sleep and morning symptoms in rheumatoid arthritis. J. Rheumatol. 10, 373–379 (1983).
Lavie, P., Nahir, M., Lorber, M. & Scharf, Y. Nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis patients. Lack of association between clinical improvement and effects on sleep. Arthritis Rheum. 34, 655–659 (1991).
Koskenvuo, K., Hublin, C., Partinen, M., Paunio, T. & Koskenvuo, M. Childhood adversities and quality of sleep in adulthood: a population-based study of 26,000 Finns. Sleep. Med. 11, 17–22 (2010).
Poon, C. Y. & Knight, B. G. Impact of childhood parental abuse and neglect on sleep problems in old age. J. Gerontol. B Psychol. Sci. Soc. Sci. 66, 307–310 (2011).
Bader, K., Schafer, V., Schenkel, M., Nissen, L. & Schwander, J. Adverse childhood experiences associated with sleep in primary insomnia. J. Sleep. Res. 16, 285–296 (2007).
Spielman, A. J., Caruso, L. S. & Glovinsky, P. B. A behavioral perspective on insomnia treatment. Psychiatr. Clin. North Am. 10, 541–553 (1987).
Van Someren, E. J. W. Brain mechanisms of insomnia: new perspectives on causes and consequences. Physiol. Rev. 101, 995–1046 (2021).
Kemp, B. R. et al. Do early-life social, behavioral, and health exposures increase later-life arthritis incidence? Res. Aging 44, 479–493 (2022).
Schwetlik, S. N., Baldock, K. L., Hill, C. L. & Ferrar, K. Chronic stress and arthritis: a scoping review. Arthritis Care Res. 74, 982–996 (2022).
Spitzer, C. et al. Gender-specific association between childhood trauma and rheumatoid arthritis: a case-control study. J. Psychosom. Res. 74, 296–300 (2013).
Yoshida, T. et al. Pain catastrophizing hinders disease activity score 28 — erythrocyte sedimentation rate remission of rheumatoid arthritis in patients with normal C-reactive protein levels. Int. J. Rheum. Dis. 24, 1520–1529 (2021).
Nerurkar, L., Siebert, S., McInnes, I. B. & Cavanagh, J. Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiatry 6, 164–173 (2019).
Vallerand, I. A., Patten, S. B. & Barnabe, C. Depression and the risk of rheumatoid arthritis. Curr. Opin. Rheumatol. 31, 279–284 (2019).
Irwin, M. R. et al. Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis. Sleep 35, 537–543 (2012).
Roberts, M. B. & Drummond, P. D. Sleep problems are associated with chronic pain over and above mutual associations with depression and catastrophizing. Clin. J. Pain. 32, 792–799 (2016).
Lee, Y. C. et al. Subgrouping of patients with rheumatoid arthritis based on pain, fatigue, inflammation, and psychosocial factors. Arthritis Rheumatol. 66, 2006–2014 (2014).
Bjurstrom, M. F., Olmstead, R. & Irwin, M. R. Reciprocal relationship between sleep macrostructure and evening and morning cellular inflammation in rheumatoid arthritis. Psychosom. Med. 79, 24–33 (2017).
Suarez-Pereira, I. et al. The role of the locus coeruleus in pain and associated stress-related disorders. Biol. Psychiatry 91, 786–797 (2022).
Weinberger, J. F. et al. Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation. Brain Behav. Immun. 47, 193–200 (2015).
Poe, G. R. et al. Locus coeruleus: a new look at the blue spot. Nat. Rev. Neurosci. 21, 644–659 (2020).
Reyes, B. A., Drolet, G. & Van Bockstaele, E. J. Dynorphin and stress-related peptides in rat locus coeruleus: contribution of amygdalar efferents. J. Comp. Neurol. 508, 663–675 (2008).
Wood, C. S., Valentino, R. J. & Wood, S. K. Individual differences in the locus coeruleus-norepinephrine system: relevance to stress-induced cardiovascular vulnerability. Physiol. Behav. 172, 40–48 (2017).
Haspula, D. & Clark, M. A. Neuroinflammation and sympathetic overactivity: mechanisms and implications in hypertension. Auton. Neurosci. 210, 10–17 (2018).
Adlan, A. M., Paton, J. F., Lip, G. Y., Kitas, G. D. & Fisher, J. P. Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis. J. Physiol. 595, 967–981 (2017).
Borbely, A. A., Daan, S., Wirz-Justice, A. & Deboer, T. The two-process model of sleep regulation: a reappraisal. J. Sleep. Res. 25, 131–143 (2016).
Collomp, K. et al. Altered diurnal pattern of steroid hormones in relation to various behaviors, external factors and pathologies: a review. Physiol. Behav. 164, 68–85 (2016).
Crofford, L. J. et al. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J. Clin. Endocrinol. Metab. 82, 1279–1283 (1997).
Straub, R. H. & Cutolo, M. Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum. 56, 399–408 (2007).
Buttgereit, F., Smolen, J. S., Coogan, A. N. & Cajochen, C. Clocking in: chronobiology in rheumatoid arthritis. Nat. Rev. Rheumatol. 11, 349–356 (2015).
Straub, R. H. et al. Inflammation is an important covariate for the crosstalk of sleep and the HPA axis in rheumatoid arthritis. Neuroimmunomodulation 24, 11–20 (2017).
Nguyen, K. D. et al. Circadian gene Bmal1 regulates diurnal oscillations of Ly6Chi inflammatory monocytes. Science 341, 1483–1488 (2013).
Scheiermann, C., Gibbs, J., Ince, L. & Loudon, A. Clocking in to immunity. Nat. Rev. Immunol. 18, 423–437 (2018).
Bieber, K. et al. Autoimmune pre-disease. Autoimmun. Rev. 22, 103236 (2023).
Miller, A. H. & Raison, C. L. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol. 16, 22–34 (2016).
Dantzer, R., O’Connor, J. C., Freund, G. G., Johnson, R. W. & Kelley, K. W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46–56 (2008).
Fang, J., Sanborn, C. K., Renegar, K. B., Majde, J. A. & Krueger, J. M. Influenza viral infections enhance sleep in mice. Proc. Soc. Exp. Biol. Med. 210, 242–252 (1995).
Imeri, L. & Opp, M. R. How (and why) the immune system makes us sleep. Nat. Rev. Neurosci. 10, 199–210 (2009).
Irwin, M. R. & Opp, M. R. Sleep health: reciprocal regulation of sleep and innate immunity. Neuropsychopharmacology 42, 129–155 (2017).
Kapas, L. et al. Spontaneous and influenza virus-induced sleep are altered in TNF-α double-receptor deficient mice. J. Appl. Physiol. 105, 1187–1198 (2008).
Davis, C. J. et al. The neuron-specific interleukin-1 receptor accessory protein is required for homeostatic sleep and sleep responses to influenza viral challenge in mice. Brain Behav. Immun. 47, 35–43 (2015).
Lange, T., Marshall, L., Spath-Schwalbe, E., Fehm, H. L. & Born, J. Systemic immune parameters and sleep after ultra-low dose administration of IL-2 in healthy men. Brain Behav. Immun. 16, 663–674 (2002).
Lue, F. A. et al. Sleep and cerebrospinal fluid interleukin-1-like activity in the cat. Inter. J. Neurosci. 42, 179–183 (1988).
Taylor-Gjevre, R. M., Gjevre, J. A., Nair, B. V., Skomro, R. P. & Lim, H. J. Improved sleep efficiency after anti-tumor necrosis factor α therapy in rheumatoid arthritis patients. Ther. Adv. Musculoskelet. Dis. 3, 227–233 (2011).
Karatas, G. et al. The evaluation of sleep quality and response to anti-tumor necrosis factor α therapy in rheumatoid arthritis patients. Clin. Rheumatol. 36, 45–50 (2017).
Detert, J. et al. Effects of treatment with etanercept versus methotrexate on sleep quality, fatigue and selected immune parameters in patients with active rheumatoid arthritis. Clin. Exp. Rheumatol. 34, 848–856 (2016).
Wells, G., Li, T. & Tugwell, P. Investigation into the impact of abatacept on sleep quality in patients with rheumatoid arthritis, and the validity of the MOS-Sleep questionnaire Sleep Disturbance Scale. Ann. Rheum. Dis. 69, 1768–1773 (2010).
Tektonidou, M. G. et al. Real-world evidence of the impact of adalimumab on work productivity and sleep measures in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Ther. Adv. Musculoskelet. Dis. 12, 1759720X20949088 (2020).
Fragiadaki, K., Tektonidou, M. G., Konsta, M., Chrousos, G. P. & Sfikakis, P. P. Sleep disturbances and interleukin 6 receptor inhibition in rheumatoid arthritis. J. Rheumatol. 39, 60–62 (2012).
Bartlett, S. J. et al. The impact of tofacitinib on fatigue, sleep, and health-related quality of life in patients with rheumatoid arthritis: a post hoc analysis of data from Phase 3 trials. Arthritis Res. Ther. 24, 83 (2022).
Irwin, M. R., Olmstead, R., Valladares, E. M., Breen, E. C. & Ehlers, C. L. Tumor necrosis factor antagonism normalizes rapid eye movement sleep in alcohol dependence. Biol. Psychiatry 66, 191–195 (2009).
Genty, M. et al. Improvement of fatigue in patients with rheumatoid arthritis treated with biologics: relationship with sleep disorders, depression and clinical efficacy. A prospective, multicentre study. Clin. Exp. Rheumatol. 35, 85–92 (2017).
Genovese, M. C. et al. Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy. Ann. Rheum. Dis. 67, 547–554 (2008).
Strand, V. et al. Tofacitinib in combination with conventional disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: patient-reported outcomes from a phase III randomized controlled trial. Arthritis Care Res. 69, 592–598 (2017).
Lind, M. J. & Gehrman, P. R. Genetic pathways to insomnia. Brain Sci. https://doi.org/10.3390/brainsci6040064 (2016).
Irwin, M. R., Olmstead, R. & Carroll, J. E. Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol. Psychiatry 80, 40–52 (2016).
Irwin, M. R., Wang, M., Campomayor, C. O., Collado-Hidalgo, A. & Cole, S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch. Intern. Med. 166, 1756–1762 (2006).
Irwin, M. R. et al. Sleep loss activates cellular inflammatory signaling. Biol. Psychiatry 64, 538–540 (2008).
Irwin, M. R., Witarama, T., Caudill, M., Olmstead, R. & Breen, E. C. Sleep loss activates cellular inflammation and signal transducer and activator of transcription (STAT) family proteins in humans. Brain Behav. Immun. 47, 86–92 (2015).
Irwin, M. R., Carrillo, C. & Olmstead, R. Sleep loss activates cellular markers of inflammation: sex differences. Brain Behav. Immun. 24, 54–57 (2010).
Motivala, S. J., Khanna, D., FitzGerald, J. & Irwin, M. R. Stress activation of cellular markers of inflammation in rheumatoid arthritis: protective effects of tumor necrosis factor α antagonists. Arthritis Rheum. 58, 376–383 (2008).
Bierhaus, A. et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc. Natl Acad. Sci. USA 100, 1920–1925 (2003).
Pace, T. W. et al. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am. J. Psychiatry 163, 1630–1633 (2006).
Parry, C., Kent, E. E., Mariotto, A. B., Alfano, C. M. & Rowland, J. H. Cancer survivors: a booming population. Cancer Epidemiol. Biomark. Prev. 20, 1996–2005 (2011).
Veldhuijzen van Zanten, J. J., Ring, C., Carroll, D. & Kitas, G. D. Increased C reactive protein in response to acute stress in patients with rheumatoid arthritis. Ann. Rheum. Dis. 64, 1299–1304 (2005).
Jacobs, R. et al. Systemic lupus erythematosus and rheumatoid arthritis patients differ from healthy controls in their cytokine pattern after stress exposure. Rheumatology 40, 868–875 (2001).
Grandner, M. A. et al. Extreme sleep durations and increased C-reactive protein: effects of sex and ethnoracial group. Sleep 36, 769–779E (2013).
Friedman, E. M. Social relationships, sleep quality, and interleukin-6 in aging women. Proc. Natl Acad. Sci. 102, 18757–18762 (2005).
Park, H. et al. Sleep and inflammation during adolescence. Psychosom. Med. 78, 677–685 (2016).
Piber, D. et al. Sleep disturbance and activation of cellular and transcriptional mechanisms of inflammation in older adults. Brain Behav. Immun. 106, 67–75 (2022).
O’Connor, M. F. & Irwin, M. R. Links between behavioral factors and inflammation. Clin. Pharmacol. Ther. 87, 479–482 (2010).
Prather, A. A., Epel, E. S., Cohen, B. E., Neylan, T. C. & Whooley, M. A. Gender differences in the prospective associations of self-reported sleep quality with biomarkers of systemic inflammation and coagulation: findings from the Heart and Soul Study. J. Psychiatr. Res. 47, 1228–1235 (2013).
Cho, H. J., Seeman, T. E., Kiefe, C. I., Lauderdale, D. S. & Irwin, M. R. Sleep disturbance and longitudinal risk of inflammation: moderating influences of social integration and social isolation in the coronary artery risk development in young adults (CARDIA) study. Brain Behav. Immun. 46, 319–326 (2015).
Hall, M. H. et al. Association between sleep duration and mortality is mediated by markers of inflammation and health in older adults: the Health, Aging and Body Composition Study. Sleep 38, 189–195 (2015).
Smagula, S. F. et al. Actigraphy- and polysomnography-measured sleep disturbances, inflammation, and mortality among older men. Psychosom. Med. 78, 686–696 (2016).
Ruiz, F. S. et al. Immune alterations after selective rapid eye movement or total sleep deprivation in healthy male volunteers. Innate Immun. 18, 44–54 (2012).
Vallat, R., Shah, V. D., Redline, S., Attia, P. & Walker, M. P. Broken sleep predicts hardened blood vessels. PLoS Biol. 18, e3000726 (2020).
Filippa, M. G. et al. Adrenocortical dysfunction in rheumatoid arthritis: alpha narrative review and future directions. Eur. J. Clin. Invest. 52, e13635 (2022).
Irwin, M., Thompson, J., Miller, C., Gillin, J. C. & Ziegler, M. Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications. J. Clin. Endocrinol. Metab. 84, 1979–1985 (1999).
Somers, V. K., Dyken, M. E., Mark, A. L. & Abboud, F. M. Sympathetic-nerve activity during sleep in normal subjects. N. Engl. J. Med. 328, 303–307 (1993).
Pongratz, G. & Straub, R. H. The sympathetic nervous response in inflammation. Arthritis Res. Ther. 16, 504 (2014).
Dekkers, J. C., Geenen, R., Godaert, G. L., Bijlsma, J. W. & van Doornen, L. J. Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin. Exp. Rheumatol. 22, 63–70 (2004).
Morssinkhof, M. W. L. et al. Associations between sex hormones, sleep problems and depression: a systematic review. Neurosci. Biobehav. Rev. 118, 669–680 (2020).
Taylor-Gjevre, R. M., Nair, B. V. & Gjevre, J. A. Obstructive sleep apnoea in relation to rheumatic disease. Rheumatology 52, 15–21 (2013).
Straub, R. H., Bijlsma, J. W., Masi, A. & Cutolo, M. Role of neuroendocrine and neuroimmune mechanisms in chronic inflammatory rheumatic diseases — the 10-year update. Semin. Arthritis Rheum. 43, 392–404 (2013).
Cutolo, M. & Straub, R. H. Sex steroids and autoimmune rheumatic diseases: state of the art. Nat. Rev. Rheumatol. 16, 628–644 (2020).
Crestani, C. C. et al. Mechanisms in the bed nucleus of the stria terminalis involved in control of autonomic and neuroendocrine functions: a review. Curr. Neuropharmacol. 11, 141–159 (2013).
Presto, P., Mazzitelli, M., Junell, R., Griffin, Z. & Neugebauer, V. Sex differences in pain along the neuraxis. Neuropharmacology 210, 109030 (2022).
Petrov, M. E. et al. Disrupted sleep is associated with altered pain processing by sex and ethnicity in knee osteoarthritis. J. Pain. 16, 478–490 (2015).
Smith, M. T. & Haythornthwaite, J. A. How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep. Med. Rev. 8, 119–132 (2004).
Bonvanie, I. J., Oldehinkel, A. J., Rosmalen, J. G. M. & Janssens, K. A. M. Sleep problems and pain: a longitudinal cohort study in emerging adults. Pain 157, 957–963 (2016).
Gupta, A. et al. The role of psychosocial factors in predicting the onset of chronic widespread pain: results from a prospective population-based study. Rheumatology 46, 666–671 (2007).
Smith, M. T. et al. Sleep onset insomnia symptoms during hospitalization for major burn injury predict chronic pain. Pain 138, 497–506 (2008).
Nicassio, P. M. et al. The contribution of pain and depression to self-reported sleep disturbance in patients with rheumatoid arthritis. Pain 153, 107–112 (2012).
Lee, E. et al. Persistent sleep disturbance: a risk factor for recurrent depression in community-dwelling older adults. Sleep 36, 1685–1691 (2013).
Cho, H. J. et al. Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study. Am. J. Psychiatry 165, 1543–1550 (2008).
Zautra, A. J. et al. Depression history, stress, and pain in rheumatoid arthritis patients. J. Behav. Med. 30, 187–197 (2007).
Moldofsky, H. Sleep and pain. Sleep. Med. Rev. 5, 385–396 (2001).
Lee, Y. C. et al. Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study. Arthritis Res. Ther. 13, R83 (2011).
Michaud, K. et al. Systematic literature review of residual symptoms and an unmet need in patients with rheumatoid arthritis. Arthritis Care Res. 73, 1606–1616 (2021).
Woolf, C. J. Central sensitization: implications for the diagnosis and treatment of pain. Pain 152, S2–S15 (2011).
Trouvin, A. P., Attal, N. & Perrot, S. Assessing central sensitization with quantitative sensory testing in inflammatory rheumatic diseases: a systematic review. Jt. Bone Spine 89, 105399 (2022).
Walsh, D. A. & McWilliams, D. F. Mechanisms, impact and management of pain in rheumatoid arthritis. Nat. Rev. Rheumatol. 10, 581–592 (2014).
Staud, R. Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions. Expert. Rev. Neurother. 12, 577–585 (2012).
Petersen, K. K., Arendt-Nielsen, L., Simonsen, O., Wilder-Smith, O. & Laursen, M. B. Presurgical assessment of temporal summation of pain predicts the development of chronic postoperative pain 12 months after total knee replacement. Pain 156, 55–61 (2015).
Edwards, R. R., Sarlani, E., Wesselmann, U. & Fillingim, R. B. Quantitative assessment of experimental pain perception: multiple domains of clinical relevance. Pain 114, 315–319 (2005).
Finan, P. H. et al. Discordance between pain and radiographic severity in knee osteoarthritis: findings from quantitative sensory testing of central sensitization. Arthritis Rheum. 65, 363–372 (2013).
Anderson, W. S., Sheth, R. N., Bencherif, B., Frost, J. J. & Campbell, J. N. Naloxone increases pain induced by topical capsaicin in healthy human volunteers. Pain 99, 207–216 (2002).
Vladimirova, N. et al. Pain sensitisation in women with active rheumatoid arthritis: a comparative cross-sectional study. Arthritis 2015, 434109 (2015).
Lee, Y. C. et al. Association between pain sensitization and disease activity in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Care Res. 70, 197–204 (2018).
Heisler, A. C. et al. Association of pain centralization and patient-reported pain in active rheumatoid arthritis. Arthritis Care Res. 72, 1122–1129 (2020).
Song, J. et al. Pain sensitization as a potential mediator of the relationship between sleep disturbance and subsequent pain in rheumatoid arthritis. Arthritis Care Res. 75, 778–784 (2023).
Trouvin, A. P. et al. Mechanisms of chronic pain in inflammatory rheumatism: the role of descending modulation. Pain https://doi.org/10.1097/j.pain.0000000000002745 (2022).
Lee, Y. C. et al. The role of sleep problems in central pain processing in rheumatoid arthritis. Arthritis Rheum. 65, 59–68 (2013).
Heisler, A. C. et al. Association of dysregulated central pain processing and response to disease-modifying antirheumatic drug therapy in rheumatoid arthritis. Arthritis Rheumatol. 72, 2017–2024 (2020).
Smith, M. T. Jr. et al. Sex differences in measures of central sensitization and pain sensitivity to experimental sleep disruption: implications for sex differences in chronic pain. Sleep https://doi.org/10.1093/sleep/zsy209 (2019).
Simpson, N. S., Scott-Sutherland, J., Gautam, S., Sethna, N. & Haack, M. Chronic exposure to insufficient sleep alters processes of pain habituation and sensitization. Pain 159, 33–40 (2018).
Smith, M. T., Edwards, R. R., McCann, U. D. & Haythornthwaite, J. A. The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep 30, 494–505 (2007).
Eichhorn, N., Treede, R. D. & Schuh-Hofer, S. The role of sex in sleep deprivation related changes of nociception and conditioned pain modulation. Neuroscience 387, 191–200 (2018).
Iacovides, S., George, K., Kamerman, P. & Baker, F. C. Sleep fragmentation hypersensitizes healthy young women to deep and superficial experimental pain. J. Pain. 18, 844–854 (2017).
Staffe, A. T. et al. Total sleep deprivation increases pain sensitivity, impairs conditioned pain modulation and facilitates temporal summation of pain in healthy participants. PLoS One 14, e0225849 (2019).
Edwards, R. R. et al. Sleep continuity and architecture: associations with pain-inhibitory processes in patients with temporomandibular joint disorder. Eur. J. Pain. 13, 1043–1047 (2009).
Watkins, L. R., Maier, S. F. & Goehler, L. E. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63, 289–302 (1995).
Sommer, C., Leinders, M. & Uceyler, N. Inflammation in the pathophysiology of neuropathic pain. Pain 159, 595–602 (2018).
Pinho-Ribeiro, F. A., Verri, W. A. Jr. & Chiu, I. M. Nociceptor sensory neuron-immune interactions in pain and inflammation. Trends Immunol. 38, 5–19 (2017).
Lautenbacher, S., Kundermann, B. & Krieg, J. C. Sleep deprivation and pain perception. Sleep. Med. Rev. 10, 357–369 (2006).
Onen, S. H., Alloui, A., Gross, A., Eschallier, A. & Dubray, C. The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J. Sleep. Res. 10, 35–42 (2001).
Roehrs, T., Hyde, M., Blaisdell, B., Greenwald, M. & Roth, T. Sleep loss and REM sleep loss are hyperalgesic. Sleep 29, 145–151 (2006).
Irwin, M. R., Olmstead, R., Bjurstrom, M. F., Finan, P. H. & Smith, M. T. Sleep disruption and activation of cellular inflammation mediate heightened pain sensitivity: a randomized clinical trial. Pain 164, 1128–1137 (2023).
Haack, M., Sanchez, E. & Mullington, J. M. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 30, 1145–1152 (2007).
Tang, N. K. Insomnia co-occurring with chronic pain: clinical features, interaction, assessments and possible interventions. Rev. Pain. 2, 2–7 (2008).
Segond von Banchet, G. et al. Experimental arthritis causes tumor necrosis factor-alpha-dependent infiltration of macrophages into rat dorsal root ganglia which correlates with pain-related behavior. Pain 145, 151–159 (2009).
Basbaum, A. I., Bautista, D. M., Scherrer, G. & Julius, D. Cellular and molecular mechanisms of pain. Cell 139, 267–284 (2009).
Ebbinghaus, M. et al. Interleukin-6-dependent influence of nociceptive sensory neurons on antigen-induced arthritis. Arthritis Res. Ther. 17, 334 (2015).
Schaible, H. G., Konig, C. & Ebersberger, A. Spinal pain processing in arthritis: neuron and glia (inter)actions. J. Neurochem. https://doi.org/10.1111/jnc.15742 (2022).
Schaible, H. G. Nociceptive neurons detect cytokines in arthritis. Arthritis Res. Ther. 16, 470 (2014).
Ebbinghaus, M. et al. The role of interleukin-1β in arthritic pain: main involvement in thermal, but not mechanical, hyperalgesia in rat antigen-induced arthritis. Arthritis Rheum. 64, 3897–3907 (2012).
Irwin, M., Clark, C., Kennedy, B., Christian Gillin, J. & Ziegler, M. Nocturnal catecholamines and immune function in insomniacs, depressed patients, and control subjects. Brain Behav. Immun. 17, 365–372 (2003).
Irwin, M. R. & Cole, S. W. Reciprocal regulation of the neural and innate immune systems. Nat. Rev. Immunol. 11, 625–632 (2011).
Miller, G. E. et al. A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-κB signaling. Biol. Psychiatry 64, 266–272 (2008).
Tracey, K. J. Reflex control of immunity. Nat. Rev. Immunol. 9, 418–428 (2009).
Koopman, F. A. et al. Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis. Mol. Med. 17, 937–948 (2011).
Adlan, A. M., Lip, G. Y., Paton, J. F., Kitas, G. D. & Fisher, J. P. Autonomic function and rheumatoid arthritis: a systematic review. Semin. Arthritis Rheum. 44, 283–304 (2014).
Reynolds, A. C., Marshall, N. S., Hill, C. L. & Adams, R. J. Systematic review of the efficacy of commonly prescribed pharmacological treatments for primary treatment of sleep disturbance in patients with diagnosed autoimmune disease. Sleep. Med. Rev. 49, 101232 (2020).
Roth, T. et al. The effect of eszopiclone in patients with insomnia and coexisting rheumatoid arthritis: a pilot study. Prim. Care Companion J. Clin. Psychiatry 11, 292–301 (2009).
Montgomery, P. & Dennis, J. Cognitive behavioural interventions for sleep problems in adults aged 60+. Cochrane Database Syst. Rev. https://doi.org/10.1002/14651858.CD003161 (2002).
Montgomery, P. & Dennis, J. Cognitive behavioural interventions for sleep problems in adults aged 60+. Update. Cochrane Database Syst. Rev. https://doi.org/10.1002/14651858.CD003161 (2003).
Morgenthaler, T. et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of sleep medicine report. Sleep 29, 1415–1419 (2006).
Riemann, D. et al. European guideline for the diagnosis and treatment of insomnia. J. Sleep. Res. 26, 675–700 (2017).
Qaseem, A. et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann. Intern. Med. 165, 125–133 (2016).
Irwin, M. R. et al. Prevention of incident and recurrent major depression in older adults with insomnia: a randomized clinical trial. JAMA Psychiatry 79, 33–41 (2022).
Irwin, M. R. et al. Tai Chi Chih compared with cognitive behavioral therapy for the treatment of insomnia in survivors of breast cancer: a randomized, partially blinded, noninferiority trial. J. Clin. Oncol. 35, 2656–2665 (2017).
Garland, S. N. et al. Mindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trial. J. Clin. Oncol. 32, 449–457 (2014).
Siu, P. M. et al. Effects of Tai Chi or exercise on sleep in older adults with insomnia: a randomized clinical trial. JAMA Netw. Open 4, e2037199 (2021).
Moldofsky, H., Lue, F. A., Mously, C., Roth-Schechter, B. & Reynolds, W. J. The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study. J. Rheumatol. 23, 529–533 (1996).
Edinger, J. D., Wohlgemuth, W. K., Krystal, A. D. & Rice, J. R. Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial. Arch. Intern. Med. 165, 2527–2535 (2005).
Drewes, A. M., Bjerregard, K., Taagholt, S. J., Svendsen, L. & Nielsen, K. D. Zopiclone as night medication in rheumatoid arthritis. Scand. J. Rheumatol. 27, 180–187 (1998).
Scharf, M. B., Baumann, M. & Berkowitz, D. V. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J. Rheumatol. 30, 1070–1074 (2003).
Walsh, J. K., Muehlbach, M. J., Lauter, S. A., Hilliker, N. A. & Schweitzer, P. K. Effects of triazolam on sleep, daytime sleepiness, and morning stiffness in patients with rheumatoid arthritis. J. Rheumatol. 23, 245–252 (1996).
Irwin, M. R., Cole, J. C. & Nicassio, P. M. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol. 25, 3–14 (2006).
Selvanathan, J. et al. Cognitive behavioral therapy for insomnia in patients with chronic pain — a systematic review and meta-analysis of randomized controlled trials. Sleep. Med. Rev. 60, 101460 (2021).
Latocha, K. M. et al. The effect of group-based cognitive behavioural therapy for insomnia in patients with rheumatoid arthritis: a randomised controlled trial. Rheumatology https://doi.org/10.1093/rheumatology/keac448 (2022).
Smith, M. T. et al. Cognitive-behavioral therapy for insomnia in knee osteoarthritis: a randomized, double-blind, active placebo-controlled clinical trial. Arthritis Rheumatol. 67, 1221–1233 (2015).
Loeppenthin, K. et al. Efficacy and acceptability of intermittent aerobic exercise on polysomnography-measured sleep in people with rheumatoid arthritis with self-reported sleep disturbance: a randomized controlled trial. ACR Open Rheumatol. 4, 395–405 (2022).
McKenna, S. G. et al. The feasibility of an exercise intervention to improve sleep (time, quality and disturbance) in people with rheumatoid arthritis: a pilot RCT. Rheumatol. Int. 41, 297–310 (2021).
Kilic, N. & Parlar Kilic, S. The effect of progressive muscle relaxation on sleep quality and fatigue in patients with rheumatoid arthritis: a randomized controlled trial. Int. J. Nurs. Pract. https://doi.org/10.1111/ijn.13015 (2021).
Ward, L., Stebbings, S., Athens, J., Cherkin, D. & David Baxter, G. Yoga for the management of pain and sleep in rheumatoid arthritis: a pilot randomized controlled trial. Musculoskelet. Care 16, 39–47 (2018).
Tang, N. K. et al. Nonpharmacological treatments of insomnia for long-term painful conditions: a systematic review and meta-analysis of patient-reported outcomes in randomized controlled trials. Sleep 38, 1751–1764 (2015).
Krueger, J. M. & Majde, J. A. Microbial products and cytokines in sleep and fever regulation. Crit. Rev. Immunol. 37, 291–315 (2017).
Motivala, S. J., Sollers, J., Thayer, J. & Irwin, M. R. Tai chi chih acutely decreases sympathetic nervous system activity in older adults. J. Gerontol. A Biol. Sci. Med. Sci. 61, 1177–1180 (2006).
Park, J., Lyles, R. H. & Bauer-Wu, S. Mindfulness meditation lowers muscle sympathetic nerve activity and blood pressure in African-American males with chronic kidney disease. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307, R93–R101 (2014).
Ardi, Z., Golland, Y., Shafir, R., Sheppes, G. & Levit-Binnun, N. The effects of mindfulness-based stress reduction on the association between autonomic interoceptive signals and emotion regulation selection. Psychosom. Med. 83, 852–862 (2021).
Black, D. S. et al. Tai chi meditation effects on nuclear factor-κB signaling in lonely older adults: a randomized controlled trial. Psychother. Psychosom. 83, 315–317 (2014).
Irwin, M. R. et al. Tai chi, cellular inflammation, and transcriptome dynamics in breast cancer survivors with insomnia: a randomized controlled trial. J. Natl Cancer Inst. Monogr. 2014, 295–301 (2014).
Irwin, M. R. et al. Cognitive behavioral therapy and tai chi reverse cellular and genomic markers of inflammation in late-life insomnia: a randomized controlled trial. Biol. Psychiatry 78, 721–729 (2015).
Ford, E. S. Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults. Epidemiology 13, 561–568 (2002).
Esposito, K. et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. J. Am. Med. Assoc. 289, 1799–1804 (2003).
Creswell, J. D. et al. Mindfulness-based stress reduction training reduces loneliness and pro-inflammatory gene expression in older adults: a small randomized controlled trial. Brain Behav. Immun. 26, 1095–1101 (2012).
Black, D. S. et al. Yogic meditation reverses NF-κB and IRF-related transcriptome dynamics in leukocytes of family dementia caregivers in a randomized controlled trial. Psychoneuroendocrinology 38, 348–355 (2013).
Zautra, A. J. et al. Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression. J. Consult. Clin. Psychol. 76, 408–421 (2008).
Kunzel, H. et al. Sleep in pituitary insufficient patients compared to patients with depression and healthy controls at baseline and after challenge with CRH. J. Psychiatr. Res. 129, 124–128 (2020).
Buckley, T. M. & Schatzberg, A. F. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J. Clin. Endocrinol. Metab. 90, 3106–3114 (2005).
Straub, R. H. et al. Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol. Ann. Rheum. Dis. 64, 1353–1356 (2005).
Zielinski, M. R., Dunbrasky, D. L., Taishi, P., Souza, G. & Krueger, J. M. Vagotomy attenuates brain cytokines and sleep induced by peripherally administered tumor necrosis factor-α and lipopolysaccharide in mice. Sleep 36, 1227–1238 (2013).
Vitkovic, L., Bockaert, J. & Jacque, C. “Inflammatory” cytokines: neuromodulators in normal brain? J. Neurochem. 74, 457–471 (2000).
Banks, W. A. The blood-brain barrier in neuroimmunology: tales of separation and assimilation. Brain Behav. Immun. 44, 1–8 (2015).
Opp, M. R. & Krueger, J. M. Sleep and immunity: a growing field with clinical impact. Brain Behav. Immun. 47, 1–3 (2015).
D’Mello, C., Le, T. & Swain, M. G. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factorα signaling during peripheral organ inflammation. J. Neurosci. 29, 2089–2102 (2009).
McEwen, B. S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 87, 873–904 (2007).
McEwen, B. S. Sleep deprivation as a neurobiologic and physiologic stressor: allostasis and allostatic load. Metabolism 55, S20–S23 (2006).
Besedovsky, L., Lange, T. & Born, J. Sleep and immune function. Pflugers Arch. 463, 121–137 (2012).
Redwine, L., Dang, J., Hall, M. & Irwin, M. Disordered sleep, nocturnal cytokines, and immunity in alcoholics. Psychosom. Med. 65, 75–85 (2003).
Irwin, M. et al. Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J. 10, 643–653 (1996).
Vgontzas, A. N. et al. Circadian interleukin-6 secretion and quantity and depth of sleep. J. Clin. Endocrinol. Metab. 84, 2603–2607 (1999).
Redwine, L., Hauger, R., Gillin, J. & Irwin, M. Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans. J. Clin. Endocrinol. Metab. 85, 3597–3603 (2000).
Muller-Newen, G. et al. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. J. Immunol. 161, 6347–6355 (1998).
Dimitrov, S., Besedovsky, L., Born, J. & Lange, T. Differential acute effects of sleep on spontaneous and stimulated production of tumor necrosis factor in men. Brain Behav. Immun. 47, 201–210 (2015).
Born, J., Lange, T., Hansen, K., Molle, M. & Fehm, H. L. Effects of sleep and circadian rhythm on human circulating immune cells. J. Immunol. 158, 4454–4464 (1997).
Acknowledgements
The work of the authors is funded by National Institutes of Health (NIH) — National Institute on Drug Abuse (NIH/NIDA) R01DA0329922 (to M.T.S. and M.R.I.), by NIH – National Heart, Lung, and Blood Institute (NIH-NHLB) R01 HL079955 (to M.R.I.), and the Norman Cousins Center for Psychoneuroimmunology.
Author information
Authors and Affiliations
Contributions
All authors contributed to all aspects of the preparation of this manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Reviews Rheumatology thanks Filip Swirski, Monica Andersen and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Glossary
- C-reactive protein
-
(CRP). An acute phase protein that is synthesized by the liver in response to the production of IL-6 by macrophages or T cells.
- Electroencephalography
-
(EEG). A measure that tracks the electrical activity of the brain; one use is to graphically represent stages of sleep, which are defined by differences in waveform shape, frequency and amplitude.
- Electromyography
-
A measure that tracks the electrical activity of muscle; it can be used, together with the EEG, to define stages of sleep, such as rapid eye movement sleep, in which low muscle tone or activity is accompanied by random and rapid eye movements.
- Epigenetic ageing
-
An estimate of biological age given by evaluating changes in DNA methylation at particular genomic locations, which is found to be more predictive of mortality risk than chronological age.
- Experimental sleep disruption
-
Imposing a loss of sleep during the night, for either part of the night (in other words, partial night sleep deprivation) or for the entire night (in other words, total night sleep deprivation).
- Glucocorticoid resistance
-
A state of decreased sensitivity to the anti-inflammatory effects of glucocorticoids, which can be caused by ongoing increases in inflammation as well as by a genetic predisposition.
- Glucocorticoids
-
Neuroendocrine hormones that belong to the steroid hormone class, which suppress inflammation and antiviral immune responses, in addition to having a role in the metabolism of protein, fat and glucose.
- Hypothalamic–pituitary–adrenal axis
-
(HPA axis). A neuroendocrine system that links the hypothalamus, pituitary and adrenal glands and functions to regulate the immune system in response to circadian signalling, behavioural states such as sleep and peripheral inflammatory signals.
- Parasympathetic nervous system
-
A component of the autonomic nervous system that comprises nerve fibres that innervate visceral tissues to regulate actions of the body when it is at rest, mainly through the release of the neurotransmitter acetylcholine.
- Rapid eye movement
-
(REM). A stage of sleep, also known as paradoxical sleep, that is characterized by desynchronized electroencephalogram activity in a manner similar to waking, accompanied by random and rapid movement of the eyes together with low muscle tone. REM sleep is viewed as the sleep period in which there is a propensity to dream.
- REM density
-
A measure specific to REM sleep and refers to the number of eye movements during REM sleep, which increases throughout the night along with a reduction in the drive to sleep. In other words, REM density is higher during the circadian or sleep period with arousal, and decreased in the night following sleep deprivation, which increases the drive to sleep.
- Sleep continuity
-
The relative distribution of uninterrupted sleep, as opposed to wakefulness, during the night, as measured by sleep efficiency and wake time after sleep onset (the amount of time spent awake after turning off the lights and initiating sleep).
- Sleep duration
-
The amount of time spent asleep during the night, measured either by subjective report or objectively, using polysomnography or actigraphy. Short sleep duration is defined as less than the reference amount of 7 h per night and is typically characterized as being less than 6 h of sleep per night. Long sleep duration is typically characterized as being more than 8 h of sleep per night.
- Sleep efficiency
-
Time spent asleep as a percentage of the total time spent in bed.
- Sympathetic nervous system
-
(SNS). A component of the autonomic nervous system that comprises nerve fibres that innervate lymphoid tissues, as well as nearly all other body tissues. The SNS regulates immune cell traffic and immune responses during sleep and in response to stress through the release of noradrenaline.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Irwin, M.R., Straub, R.H. & Smith, M.T. Heat of the night: sleep disturbance activates inflammatory mechanisms and induces pain in rheumatoid arthritis. Nat Rev Rheumatol 19, 545–559 (2023). https://doi.org/10.1038/s41584-023-00997-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-023-00997-3
This article is cited by
-
Inhibition of LSD1 via SP2509 attenuated the progression of rheumatoid arthritis
Immunologic Research (2024)